West to Host Fourth-Quarter and Full-Year 2021 Conference Call

Rhea-AI Summary

West Pharmaceutical Services, a leader in injectable drug administration, will announce its fourth-quarter and full-year 2021 financial results on February 17, 2022, before the market opens. A conference call to discuss these results is scheduled for 9:00 a.m. ET on the same day. Participants can join by calling 877-930-8295 (U.S.) or 253-336-8738 (International), using conference ID 1986145. An archive of the call will be available for review until February 24, 2022. For more information, visit www.westpharma.com.

EXTON, Pa., Feb. 3, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2021 financial results before the market opens on Thursday, February 17, 2022, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call, please dial 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is 1986145.

A live broadcast of the conference call will be available at the Company's website, www.westpharma.com, in the "Investors" section. Management will refer to a slide presentation during the call, which will be made available on the day of the call. To view the presentation, select "Presentations" in the "Investors" section of the Company's website. 

An online archive of the broadcast will be available at the site three hours after the live call and will be available through Thursday, February 24, 2022, by dialing 855-859-2056 (U.S.) or 404-537-3406  (International). The conference ID is 1986145.

About West

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With almost 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 40 billion components and devices each year.

Headquartered in Exton, Pennsylvania, and in business for nearly a century, West in its fiscal year 2020 generated over $2.15 billion in sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit https://www.westpharma.com/.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-host-fourth-quarter-and-full-year-2021-conference-call-301474129.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

When will West Pharmaceutical Services release its 2021 financial results?

West Pharmaceutical Services will release its fourth-quarter and full-year 2021 financial results on February 17, 2022.

What time is the conference call for West Pharmaceutical Services financial results?

The conference call is scheduled for 9:00 a.m. Eastern Time on February 17, 2022.

How can I participate in the West Pharmaceutical Services conference call?

To participate in the conference call, dial 877-930-8295 (U.S.) or 253-336-8738 (International) and use conference ID 1986145.

Will there be a recording of the West Pharmaceutical Services conference call?

Yes, an online archive of the conference call will be available three hours after the live event until February 24, 2022.

Where can I find more information about West Pharmaceutical Services?

More information about West Pharmaceutical Services can be found on their website at www.westpharma.com.